FDA updates labeling for IMITREX FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN. Decision date: 12/09/2025 Full text
There are no comments here yet...